X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (654) 654
humans (613) 613
female (497) 497
male (493) 493
aged (424) 424
cardiac & cardiovascular systems (424) 424
middle aged (417) 417
mortality (338) 338
risk factors (319) 319
adult (218) 218
denmark - epidemiology (214) 214
aged, 80 and over (204) 204
heart failure (182) 182
risk (173) 173
registries (162) 162
prognosis (161) 161
abridged index medicus (158) 158
epidemiology (155) 155
cohort studies (125) 125
incidence (120) 120
atrial fibrillation (118) 118
proportional hazards models (118) 118
follow-up studies (113) 113
research (111) 111
care and treatment (109) 109
denmark (108) 108
peripheral vascular disease (108) 108
time factors (103) 103
cardiovascular (102) 102
heart attacks (100) 100
retrospective studies (99) 99
treatment outcome (99) 99
stroke (97) 97
comorbidity (93) 93
myocardial infarction (92) 92
cardiology (88) 88
cardiac patients (86) 86
cardiovascular disease (85) 85
survival (85) 85
heart attack (84) 84
population (84) 84
drug therapy (82) 82
medicine, general & internal (82) 82
hypertension (80) 80
health aspects (79) 79
heart failure - mortality (78) 78
myocardial infarction - mortality (78) 78
myocardial-infarction (77) 77
patients (74) 74
risk assessment (73) 73
acute myocardial-infarction (72) 72
medical research (72) 72
patient outcomes (72) 72
analysis (71) 71
cardiovascular diseases (71) 71
diabetes (71) 71
disease (71) 71
internal medicine (69) 69
studies (65) 65
diagnosis (62) 62
double-blind method (61) 61
association (59) 59
therapy (59) 59
usage (59) 59
health risk assessment (58) 58
medicine, experimental (58) 58
young adult (58) 58
heart failure - drug therapy (57) 57
management (57) 57
outcomes (57) 57
research article (57) 57
prevalence (56) 56
atrial fibrillation - drug therapy (55) 55
metaanalysis (55) 55
myocardial infarction - drug therapy (55) 55
cardiac arrhythmia (54) 54
death (52) 52
hospitalization (52) 52
survival analysis (50) 50
complications and side effects (49) 49
hospitals (49) 49
adrenergic beta-antagonists - therapeutic use (48) 48
cardiovascular diseases - mortality (48) 48
trial (48) 48
blood pressure (47) 47
multivariate analysis (47) 47
adolescent (46) 46
medicine (46) 46
prevention (46) 46
confidence intervals (45) 45
guidelines (45) 45
heart (45) 45
medical and health sciences (44) 44
medicin och hälsovetenskap (44) 44
prospective studies (44) 44
warfarin (44) 44
age factors (43) 43
morbidity (43) 43
cardiac arrest (42) 42
anti-arrhythmia agents - therapeutic use (41) 41
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European heart journal, ISSN 0195-668X, 06/2019
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2015, Volume 113, Issue 6, pp. 1165 - 1169
Journal Article
by Connolly, Stuart J and Eikelboom, John W and Bosch, Jackie and Dagenais, Gilles and Dyal, Leanne and Lanas, Fernando and Metsarinne, Kaj and O'Donnell, Martin and Dans, Anthony L and Ha, Jong-Won and Parkhomenko, Alexandr N and Avezum, Alvaro A and Lonn, Eva and Lisheng, Liu and Torp-Pedersen, Christian and Widimsky, Petr and Maggioni, Aldo P and Felix, Camilo and Keltai, Katalin and Hori, Masatsugu and Yusoff, Khalid and Guzik, Tomasz J and Bhatt, Deepak L and Branch, Kelley R H and Cook Bruns, Nancy and Berkowitz, Scott D and Anand, Sonia S and Varigos, John D and Fox, Keith A A and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, RANDOLPH and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ZIMMERMANN, SERGIO LUIZ and RECH, RAFAEL and ... and COMPASS Investigators and COMPASS investigators
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 205 - 218
Coronary artery disease is a major cause of morbidity and mortality worldwide, and is a consequence of acute thrombotic events involving activation of... 
PREVENTION | MEDICINE, GENERAL & INTERNAL | ORAL RIVAROXABAN | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Male | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Coronary Artery Disease - drug therapy | Morbidity | Factor Xa Inhibitors - therapeutic use | Factor Xa Inhibitors - adverse effects | Aged | Coronary Artery Disease - epidemiology | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Anticoagulants | Aspirin | Stroke | Heart attacks | Mortality | Coronary artery | Clinical trials | Cardiovascular disease | Coronary artery disease | Disease control | Disease prevention | Coronary vessels | Acute coronary syndromes | Thromboembolism | Health risk assessment | Drug therapy | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2018, Volume 72, Issue 17, pp. 2093 - 2094
Journal Article
Heart, ISSN 1355-6037, 07/2017, Volume 103, Issue 14, pp. 1063 - 1064
[...]a few decades ago, nearly no one survived out-of-hospital cardiac arrest. 1 A recently published meta-analysis of 79 outcome studies from around the world... 
Cardiac arrest | Consortia | Heart | Studies | Cardiac arrhythmia | Patients | Cardiopulmonary resuscitation--CPR | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article
PLoS genetics, ISSN 1553-7390, 10/2018, Volume 14, Issue 10, pp. e1007667 - e1007667
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2015, Volume 372, Issue 16, pp. 1489 - 1499
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 05/2018, Volume 33, Issue suppl_1, pp. i3 - i3
Journal Article